Sign In
Buy GOSS
$0.188
-0.0119 (-5.94%)
At Close: Jun 03, 2026
New York, New York--(Newsfile Corp. - May 29, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Gossamer Bio, Inc. (NASDAQ: GOSS) alleging
Investors who purchased the Company's securities pursuant and/or traceable to the Company's initial public offering in February 2019 (the "IPO" ) or between February 8, 2019 and December 13, 2019, inc
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of GOSS, SERV and HALL
05:45pm, Friday, 29'th May 2020
NEW YORK, NY / ACCESSWIRE / May 29, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly-traded companies. Sh
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Gossamer Bio, Inc. (NASDAQ: GOSS) (i) pursuant and/or traceable to the Company’s initial public offering in
New York, New York--(Newsfile Corp. - May 29, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Gos
Los Angeles, California--(Newsfile Corp. - May 29, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Gossamer Bio, Inc.
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflamm
CLASS ACTION UPDATE for GOSS, GSX and GRPN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
01:20am, Friday, 29'th May 2020
NEW YORK, NY / ACCESSWIRE / May 28, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders
LOS ANGELES, CA / ACCESSWIRE / May 28, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against Gossamer Bio, Inc. ("Gossamer"
The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant
12:00am, Friday, 29'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 28)
ADC Therapeutics SA (NYSE:...
7 High-Risk Stocks For Market Gamblers
06:55pm, Thursday, 28'th May 2020
Casinos are just starting to open back up following COVID-19 shutdowns, but it may still be a while before some gamblers are willing to venture back to Vegas or even their local casino. Sports gambler
New York, New York--(Newsfile Corp. - May 28, 2020) - Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Gossamer Bio, Inc. ("Gossamer " or "the Co
New York, New York--(Newsfile Corp. - May 28, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Gossamer Bio, Inc. (NASDAQ: GOSS) alleging
New York, New York--(Newsfile Corp. - May 28, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Gossamer Bio, Inc. (NASDAQ: GOSS) ("Gossamer" or the "Company
Los Angeles, California--(Newsfile Corp. - May 28, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Gossamer Bio, Inc.
